Significant Ownership of Braeden Lichti

Signature - Title
/s/ Braeden Lichti - Braeden Lichti
Location
Vancouver, British Columbia, Canada
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Braeden Lichti.

Follow Filing Activity

Follow Braeden Lichti and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Significant Ownership of Braeden Lichti

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ELAB PMGC Holdings Inc. Series B Preferred Stock, par value $0.0001 per share 52% 3,336,437 Braeden Lichti 26 Mar 2025
NVNO enVVeno Medical Corp Common Stock, par value $0.00001 per share 5% $331,842 33,151 0% Braeden Lichti 20 Feb 2026
NVNO enVVeno Medical Corp Common Stock, par value $0.00001 per share 5% $331,842 33,151 0% Braeden Lichti 20 Feb 2026
BJDX Bluejay Diagnostics, Inc. Common Stock, par value $0.0001 per share 3.6% $115,375 35,500 0% Braeden Lichti 11 Mar 2026
BJDX Bluejay Diagnostics, Inc. Common Stock, par value $0.0001 per share 3.6% $115,375 35,500 0% Braeden Lichti 11 Mar 2026
ELAB PMGC Holdings Inc. Common Stock, par value $0.0001 per share 0.19% $6,395 2,733 Braeden Lichti 24 Sep 2024
ENVB ENVERIC BIOSCIENCES, INC. Common Stock, $0.01 par value per share 0% $0 -$163,363 0 -100% Braeden Lichti 09 Dec 2025

Schedules 13D/G Reported by Braeden Lichti:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .